Current location - Trademark Inquiry Complete Network - Tian Tian Fund - Research topics of scientific research projects in Yang Xia
Research topics of scientific research projects in Yang Xia
The Key Role and Mechanism of 1.VDAC in Apoptosis of Cervical Cancer Cells and Endothelial Cells Induced by Human Plasminogen K5 (General Project of National Natural Science Foundation of China): Yang Xia.

Person in charge: Yang Xia Participants: Qingwu, Yao Yachao, Li Lei, Li Shuai, Huang Lijun, Lu Juling and Lan Xiujian Fund: 700,000 yuan Year: 20 12.

2. Obtaining of marine microbial secondary metabolite G503 and its anti-tumor activity (Guangzhou Science and Technology Plan Project): Yang Xia.

Person in charge: Yang Xia Participants: She Zhigang, Zhou Ti, Li Hanxiang, Li Cen, Huang Lijun, Li Lei and Xie Jinwei. Fund:150,000 Yuan Year: 20 12.

3. Obtaining of marine microbial secondary metabolite G503 and its anti-tumor activity (Guangdong Science and Technology Plan Project): Yang Xia.

Person in charge: Yang Xia participants:, Dai Zhiyu,, Li Lei, Gao, Lin Yongcheng and Xie Jinwei. Fund: 80,000 yuan. Year: 20 1 1.

4. Molecular Mechanism of 4.K5 Down-regulating GRP78-induced Apoptosis of Hepatoma Cells and Endothelial Cells (General Project of National Natural Science Foundation of China): Yang Xia.

Person in charge: Yang Xia Participants:, Fang Shuhuan, Yuan, Duan Junting, Yue Jinya and Lan Xiujian Contribution: 365,438+00,000 Yuan Year: 2009.

5. Inhibitory effect of mutant K5 on angiogenesis of hepatocellular carcinoma and its signal transduction (Youth Fund of National Natural Science Foundation of China): Yang Xia

Person in charge: Yang Xia Participants:, Yang, He, Cheng Rui, Wen Nan, Zhou Contribution: 230,000 yuan Year: 2007.

6. Study of angiogenesis inhibitor KBP gene nano-carrier in the treatment of liver cancer (Guangzhou Science and Technology Project): Yang Xia.

Person in charge: Yang Xia Participants: Yuan, Xu Zumin, Yang, Cai Weibin, Gao, Liu Ranyi, Zhou Funded amount: 200,000 yuan Year: 2008.

7. Candidate new drug for genetic engineering treatment of liver cancer with angiogenesis as the target (national major science and technology project): Gao.

Person in charge: Gao Participant:, Yang Xia, Zhong, Cai Weibin, Yang, He Guangyao, Lan Xiujian Fund: 654.38+500 million Yuan Year: 2009.

8. Key amino acids and spatial structure characteristics of anti-angiogenic activity of human plasminogen K5 (operating expenses of basic scientific research in universities of Ministry of Education, training program for young teachers of Sun Yat-sen University): Yang Xia.

Person in charge: Yang Xia Participants: Hou Jing, Xu Zumin, Yao Yachao, Chen Yifei, Lan Xiujian Fund: 65,438+050,000 yuan; year: 2,065,438+00.